Psychiatric News (1/5) reported, “Taking serotonergic antidepressants such as serotonin and norepinephrine reuptake inhibitors (SNRIs) or selective serotonin reuptake inhibitors (SSRIs) may increase the risk of patients with Parkinson’s disease developing impulse control disorder, a study…has found.” Investigators came to this conclusion after examining “data from 1,045 individuals (mean age, 63 years) who were participating in the Parkinson’s Progression Markers Initiative.” The research was published in The American Journal of Geriatric Psychiatry.
Related Links:
— “Certain Antidepressants May Increase Risk of Impulse Control Disorder in Parkinson’s Patients,” Psychiatric News, January 5, 2024